Whitepaper: Automated cell culture and screening
Posted: 8 February 2021 | Ncardia | No comments yet
This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic screening, using validated phenotypic assays.
Effective drug discovery and development relies heavily on the availability of predictive preclinical models. Successful drug efficacy screening requires not only a physiologically relevant cell model, but also validated high throughput screening protocols to test compound effects. This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic compound screening, using validated phenotypic assays.
Related content from this organisation
Related topics
Analytical techniques, Assays, Bioengineering, Biomarkers, Biopharmaceuticals, Cell culture, Disease research, Drug Development, Drug Discovery, High Throughput Screening (HTS), Hit-to-Lead, Imaging, Lab Automation, Screening, Stem Cells, Targets, toxicology
Related organisations
Ncardia